Zydus Lifesciences Completes Investment in Torrent Urja 25 with Rs 90.18 Million Share Subscription
Zydus Lifesciences and its subsidiaries have completed the final tranche of investment in Torrent Urja 25, subscribing to equity shares worth Rs 90.18 million and concluding the transaction initiated under the Share Subscription and Shareholders’ Agreements (SSSAs).
Pharma Deals | 20/05/2026 | By News Bureau
Eris Lifesciences to Increase Its Stake in Swiss Parenterals
Eris Lifesciences has announced plans to consolidate its stake in Swiss Parenterals, while bringing Naishadh Shah on board as a top-10 shareholder and part of the management, strengthening its leadership and long-term strategic vision.
Pharma Deals | 27/11/2025 | By Dineshwori | 114
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy